These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11681761)

  • 21. Depressive and anxiety disorders in women with HIV infection.
    Morrison MF; Petitto JM; Ten Have T; Gettes DR; Chiappini MS; Weber AL; Brinker-Spence P; Bauer RM; Douglas SD; Evans DL
    Am J Psychiatry; 2002 May; 159(5):789-96. PubMed ID: 11986133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The management of treatment resistance in depressed patients with substance use disorders.
    Nunes EV; Deliyannides D; Donovan S; McGrath PJ
    Psychiatr Clin North Am; 1996 Jun; 19(2):311-27. PubMed ID: 8827192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
    Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008324. PubMed ID: 23152255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of severe depression.
    Thase ME
    J Clin Psychiatry; 2000; 61 Suppl 1():17-25. PubMed ID: 10703759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An illustration of how a self-report diagnostic screening scale could improve the internal validity of antidepressant efficacy trials.
    Zimmerman M; Chelminski I; Posternak M
    J Affect Disord; 2004 May; 80(1):79-85. PubMed ID: 15094261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of personality disorders to treatment outcome in depressed outpatients.
    Mulder RT; Joyce PR; Luty SE
    J Clin Psychiatry; 2003 Mar; 64(3):259-64. PubMed ID: 12716266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychiatric comorbidity in substance abuse (opioids).
    Ahmad B; Mufti KA; Farooq S
    J Pak Med Assoc; 2001 May; 51(5):183-6. PubMed ID: 11467240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual diagnosis subtypes in urban substance abuse and mental health clinics.
    Hien D; Zimberg S; Weisman S; First M; Ackerman S
    Psychiatr Serv; 1997 Aug; 48(8):1058-63. PubMed ID: 9255839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical diagnosis of substance use disorders in private psychiatric populations.
    Miller NS; Belkin BM; Gibbons R
    J Subst Abuse Treat; 1994; 11(4):387-92. PubMed ID: 7966510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing treatment adherence among outpatients with depression and cocaine dependence: results of a pilot study.
    Daley DC; Salloum IM; Zuckoff A; Kirisci L; Thase ME
    Am J Psychiatry; 1998 Nov; 155(11):1611-3. PubMed ID: 9812129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison between dually diagnosed inpatients with and without Axis II comorbidity and the relationship to treatment outcome.
    Ross S; Dermatis H; Levounis P; Galanter M
    Am J Drug Alcohol Abuse; 2003 May; 29(2):263-79. PubMed ID: 12765206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric care of patients with depression and comorbid substance use disorders.
    Montoya ID; Svikis D; Marcus SC; Suarez A; Tanielian T; Pincus HA
    J Clin Psychiatry; 2000 Sep; 61(9):698-705; quiz 706. PubMed ID: 11030495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.
    Barrowclough C; Haddock G; Tarrier N; Lewis SW; Moring J; O'Brien R; Schofield N; McGovern J
    Am J Psychiatry; 2001 Oct; 158(10):1706-13. PubMed ID: 11579006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychotherapy alone and combined with pharmacotherapy in the treatment of depression.
    de Jonghe F; Hendricksen M; van Aalst G; Kool S; Peen V; Van R; van den Eijnden E; Dekker J
    Br J Psychiatry; 2004 Jul; 185():37-45. PubMed ID: 15231554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reductions in HIV risk behaviors among depressed drug injectors.
    Stein MD; Anderson BJ; Solomon DA; Herman DS; Ramsey SE; Brown RA; Miller IW
    Am J Drug Alcohol Abuse; 2005; 31(3):417-32. PubMed ID: 16161727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual diagnosis in Spain.
    Gual A
    Drug Alcohol Rev; 2007 Jan; 26(1):65-71. PubMed ID: 17364838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.
    Zisook S; Peterkin J; Goggin KJ; Sledge P; Atkinson JH; Grant I
    J Clin Psychiatry; 1998 May; 59(5):217-24. PubMed ID: 9632030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network.
    Nolen WA; Luckenbaugh DA; Altshuler LL; Suppes T; McElroy SL; Frye MA; Kupka RW; Keck PE; Leverich GS; Post RM
    Am J Psychiatry; 2004 Aug; 161(8):1447-54. PubMed ID: 15285972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.